Clinical
Clinical
Autopsy findings reveal venous thromboembolism in patients with COVID-19
What pathologic features contribute to the cause of death in COVID-19?
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
News
New reports help nail down myocarditis risk with COVID-19 vaccine
Myocarditis linked to the two mRNA SARS-CoV-2 vaccines is rare, usually mild and self-limited, and a lot less likely than the usually more severe...
News
Merck seeks FDA authorization for antiviral COVID-19 pill
If the FDA grants authorization, the drug would be the first oral antiviral treatment for COVID-19.
News
HEPA filters may clean SARS-CoV-2 from the air: Study
"Airborne SARS-CoV-2 was detected in the ward on all five days before activation of air/UV filtration, but on none of the five days when the air/...
News
Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine
“These are typically mild cases and individuals tend to recover within a short time following standard treatment and rest,” a spokesperson for...
News
Case reports underscore risk of cerebral edema, AFCE in children with COVID-19
Neurologists urge colleagues to watch for similar cases in children.
Perspectives
Why this round of COVID-19 feels worse
The national wave of resistance to vaccination is spurring an exodus from health care.
News
Merck’s new COVID-19 pill: ‘Game changer’ or just one more tool?
“It’s not exactly a home run, like penicillin for strep throat ... but it is encouraging.”
News
Former FDA chief Gottlieb expects Delta to be last big pandemic wave in U.S.
“It’s largely coursed its way through the U.S., and so maybe by Thanksgiving, on the back-end of that, we’ll start to see prevalence levels...